Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 15.70B P/E 44.69 EPS this Y - Ern Qtrly Grth -95.40%
Income 183.35M Forward P/E 22.42 EPS next Y 11.60% 50D Avg Chg 5.00%
Sales 2.73B PEG 2.57 EPS past 5Y 8.78% 200D Avg Chg -3.00%
Dividend N/A Price/Book 1.99 EPS next 5Y 8.57% 52W High Chg -24.00%
Recommedations 2.20 Quick Ratio 1.66 Shares Outstanding 123.53M 52W Low Chg 13.00%
Insider Own 0.28% ROA 1.53% Shares Float 111.71M Beta 1.09
Inst Own 88.08% ROE 2.31% Shares Shorted/Prior 3.60M/3.17M Price 125.12
Gross Margin 55.52% Profit Margin 5.49% Avg. Volume 878,546 Target Price 125.98
Oper. Margin 8.55% Earnings Date Jul 30 Volume 1,341,776 Change 2.03%
About Revvity, Inc.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Revvity, Inc. News
11:47 AM Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript
04/30/24 Company News for Apr 30, 2024
04/30/24 Revvity Inc (RVTY) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
04/29/24 Q1 2024 Revvity Inc Earnings Call
04/29/24 Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates
04/29/24 Revvity Inc (RVTY) Q1 Earnings: Adjusted EPS Beats Estimates, Revenue Declines
04/29/24 Revvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to Say
04/29/24 Revvity beats quarterly estimates on demand for diagnostic equipment
04/29/24 Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates
04/29/24 Revvity Announces Financial Results for the First Quarter of 2024
04/25/24 Revvity Board Declares Quarterly Dividend
04/25/24 Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
04/25/24 Revvity to Present at BofA Securities 2024 Health Care Conference
04/24/24 Revvity Unveils a New Era of Automated Tuberculosis Testing
04/22/24 Investors in Revvity (NYSE:RVTY) have unfortunately lost 25% over the last three years
04/16/24 Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up
04/15/24 Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
04/10/24 Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar?
04/06/24 Revvity, Inc. (NYSE:RVTY) is largely controlled by institutional shareholders who own 80% of the company
04/04/24 Revvity To Hold Earnings Call on Monday, April 29, 2024
RVTY Chatroom

User Image TheTradingAnalyst Posted - 13 hours ago

$RVTY with a bullish setup... $SPX $SPY $QQQ Cute bottom setup. Good luck. Real-time alerts at http://thetradinganalyst.com

User Image DonCorleone77 Posted - 04/29/24

$RVTY Revvity still sees 2024 non-GAAP EPS $4.55-$4.75, consensus Lowers 2024 revenue view to $2.76B-$2.82B from $2.79B-$2.85B, consensus $2.82B.

User Image DonCorleone77 Posted - 04/29/24

$RVTY Revvity reports Q1 adjusted EPS 98c, consensus 93c Reports Q1 revenue $650M, consensus $646.84M. "It was great to see the significant progress we achieved on our strategic priorities during the first few months of the year," said CEO Prahlad Singh. "We were able to bring a number of cutting-edge innovations to market while continuing to make meaningful traction on optimizing the business as we work through this period of industry adjustment. The improvements we have made position us extremely well to deliver differentiated performance in the years to come."

User Image Stock_Titan Posted - 04/29/24

$RVTY $PKI Revvity Announces Financial Results for the First Quarter of 2024 https://www.stocktitan.net/news/RVTY/revvity-announces-financial-results-for-the-first-quarter-of-fnz5rf5f6ho6.html

User Image eWhispers Posted - 04/28/24

It is the busiest week for earnings releases among the S&P 500 $SPY with Health Care $XLV among the most represented. They've been the laggards during the quarter with 78% underperforming the S&P 500 since reporting earnings, but now sentiment has fallen to the October lows for the group ahead of earnings. https://www.earningswhispers.com/market $RVTY $GEHC $LLY

User Image Stock_Titan Posted - 04/25/24

$RVTY $PKI Revvity to Present at BofA Securities 2024 Health Care Conference https://www.stocktitan.net/news/RVTY/revvity-to-present-at-bof-a-securities-2024-health-care-w3f2bp2pb2ne.html

User Image Stock_Titan Posted - 04/24/24

$RVTY $PKI Revvity Unveils a New Era of Automated Tuberculosis Testing https://www.stocktitan.net/news/RVTY/revvity-unveils-a-new-era-of-automated-tuberculosis-cd3yzd6uoow7.html

User Image Stock_Titan Posted - 04/15/24

$RVTY $PKI Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners https://www.stocktitan.net/news/RVTY/revvity-signals-software-s-new-synergy-solution-redefines-3f05eus2yxlf.html

User Image StockInvest_us Posted - 04/09/24

Signal alert: $RVTY - Double Bottom https://stockinvest.us/l/9jGfhMhRad

User Image Stocksrunner Posted - 04/09/24

$RVTY signals a bullish trend as shares cross above the 200-day moving average ($107.03), reaching highs at $110.82 per share. Currently up 4.1% on the day, keep an eye on potential continued momentum. https://stocksrunner.com/symbol/RVTY

User Image stockpicker63 Posted - 04/09/24

Stocks to watch today! $RVTY, $VFC, $SEDG and $IGT .

User Image Stock_Titan Posted - 04/04/24

$RVTY $PKI Revvity To Hold Earnings Call on Monday, April 29, 2024 https://www.stocktitan.net/news/RVTY/revvity-to-hold-earnings-call-on-monday-april-29-3ps14pqpz9uh.html

User Image Stock_Titan Posted - 04/02/24

$RVTY $PKI Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software https://www.stocktitan.net/news/RVTY/preliminary-injunction-granted-to-enforce-revvity-s-rights-and-cloud-r8l37tiod4cr.html

User Image Stock_Titan Posted - 03/20/24

$RVTY $PKI Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group https://www.stocktitan.net/news/RVTY/revvity-files-complaint-and-seeks-injunctive-relief-against-cloud-bfmny9z0yra3.html

User Image Stock_Titan Posted - 03/18/24

$RVTY $PKI Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication https://www.stocktitan.net/news/RVTY/revvity-signals-software-introduces-signals-chem-draw-offering-to-sd0tbsck9vrl.html

User Image TheOptionsOracleUSA Posted - 02/28/24

$RVTY 🚀a Triple Bottom was confirmed on 2/27 📉This pattern tells us that the price seems to have reached a bottom after failing to break through a support level and ultimately rising higher in a sign of reversal to a new uptrend.🎯 Target Price of $110.75 - $112.00

User Image Stock_Titan Posted - 02/21/24

$RVTY $PKI Revvity to Present at Upcoming Investor Conferences https://www.stocktitan.net/news/RVTY/revvity-to-present-at-upcoming-investor-pi1krzqgpytn.html

User Image Stock_Titan Posted - 02/12/24

$RVTY $PKI Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions https://www.stocktitan.net/news/RVTY/revvity-signals-software-unveils-signals-clinical-solution-to-ae2as86xni9y.html

User Image insiderbuyingselling Posted - 02/07/24

$RVTY new insider selling: 15475 shares. http://insiderbuyingselling.com/?t=RVTY

User Image briefingcom Posted - 3 months ago

$RVTY (+4.5%): Revvity beats by $0.09, beats on revs; guides FY24 EPS in-line, revs above consensus https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240201060918RVTY&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image DonCorleone77 Posted - 3 months ago

$RVTY Revvity sees 2024 EPS $4.55-$4.75, consensus $4.60 Sees 2024 revenue $2.79B-$2.85B, consensus $2.78B.

User Image DonCorleone77 Posted - 3 months ago

$RVTY Revvity reports Q4 adjusted EPS $1.25, consensus $1.16 Reports Q4 revenue $696M, consensus $677.94M. "We persevered through continued industry headwinds and performed better than anticipated during the final months of 2023," said CEO Prahlad Singh. "We are leading with innovation to be a strategic scientific partner with our customers, which positions us well to continue to perform at a high level for years to come."

User Image coolguy0201 Posted - 01/29/24

$RVTY why 10 dollars drop in premarket.Any glitch?

User Image Last10K Posted - 01/26/24

$RVTY just filed with the SEC a Event for Officers https://last10k.com/sec-filings/RVTY/0001157523-24-000120.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=RVTY

User Image dividendinvestorbyeagle Posted - 01/25/24

$RVTY announced a dividend (Revvity Inc) https://www.dividendinvestor.com/dn/5680625 http://dlvr.it/T1td1m

User Image ChartMill Posted - 01/17/24

The 3 year average ROIC (8.12%) for $RVTY is well above the current ROIC(2.77%). The reason for the recent decline needs to be investigated. https://www.chartmill.com/stock/analyzer/stock/RVTY?view=fundamental-analysis&key=8e4fc160-babc-48e5-9935-7a55d39e49aa&utm_source=PROFITABILITY&utm_medium=stocktwits&utm_campaign=FA&utm_content=RVTY

User Image risenhoover Posted - 01/17/24

$RVTY RVTY / Revvity, Inc. downgraded by UBS https://fintel.io/sfo/us/rvty?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=upgrade

User Image TrendyChart Posted - 01/10/24

$RVTY When others stumble, certain stocks soar, showing their market strength. 💹💼 https://share.trendspider.com/chart/RVTY/804378o8v7a

User Image tickeron Posted - 01/10/24

Does this make you nervous? $RVTY MACD Histogram turned positive on January 9, 2024. View odds of downtrend. https://srnk.us/go/4964973

User Image TrendyChart Posted - 01/09/24

$RVTY When others stumble, certain stocks soar, showing their market strength. 💹💼 https://share.trendspider.com/chart/RVTY/804376znxsh

Analyst Ratings
Baird Outperform Apr 30, 24
TD Cowen Buy Apr 30, 24
Stifel Hold Feb 2, 24
Keybanc Overweight Feb 2, 24
Raymond James Outperform Feb 2, 24
Barclays Equal-Weight Jan 25, 24
UBS Neutral Jan 16, 24
Evercore ISI Group Outperform Jan 4, 24
Wells Fargo Equal-Weight Dec 19, 23